Sands Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-5,565,620
| Closed | -$375M | – | 76 |
|
|
2019
Q3 | $375M | Sell |
5,565,620
-166,343
| -3% | -$11.2M | 1.21% | 27 |
|
|
2019
Q2 | $491M | Sell |
5,731,963
-149,483
| -3% | -$12.8M | 1.46% | 24 |
|
|
2019
Q1 | $522M | Sell |
5,881,446
-226,014
| -4% | -$20.1M | 1.61% | 23 |
|
|
2018
Q4 | $520M | Sell |
6,107,460
-339,085
| -5% | -$28.9M | 1.86% | 20 |
|
|
2018
Q3 | $625M | Sell |
6,446,545
-483,654
| -7% | -$46.9M | 1.77% | 20 |
|
|
2018
Q2 | $653M | Sell |
6,930,199
-317,652
| -4% | -$29.9M | 1.87% | 22 |
|
|
2018
Q1 | $588M | Sell |
7,247,851
-478,927
| -6% | -$38.8M | 1.74% | 23 |
|
|
2017
Q4 | $689M | Sell |
7,726,778
-331,781
| -4% | -$29.6M | 2.09% | 17 |
|
|
2017
Q3 | $750M | Sell |
8,058,559
-446,922
| -5% | -$41.6M | 2.25% | 17 |
|
|
2017
Q2 | $772M | Sell |
8,505,481
-466,924
| -5% | -$42.4M | 2.32% | 16 |
|
|
2017
Q1 | $788M | Sell |
8,972,405
-408,397
| -4% | -$35.8M | 2.47% | 14 |
|
|
2016
Q4 | $777M | Sell |
9,380,802
-840,480
| -8% | -$69.6M | 2.71% | 14 |
|
|
2016
Q3 | $946M | Sell |
10,221,282
-697,035
| -6% | -$64.5M | 2.78% | 14 |
|
|
2016
Q2 | $849M | Sell |
10,918,317
-643,187
| -6% | -$50M | 2.63% | 15 |
|
|
2016
Q1 | $954M | Sell |
11,561,504
-75,962
| -0.7% | -$6.27M | 2.82% | 13 |
|
|
2015
Q4 | $1.22B | Buy |
11,637,466
+241,600
| +2% | +$25.3M | 3.14% | 12 |
|
|
2015
Q3 | $1.2B | Sell |
11,395,866
-231,741
| -2% | -$24.4M | 3.35% | 11 |
|
|
2015
Q2 | $1.59B | Sell |
11,627,607
-707,845
| -6% | -$96.8M | 3.91% | 8 |
|
|
2015
Q1 | $1.54B | Buy |
12,335,452
+152,339
| +1% | +$19M | 3.66% | 11 |
|
|
2014
Q4 | $1.1B | Buy |
12,183,113
+84,485
| +0.7% | +$7.64M | 2.62% | 18 |
|
|
2014
Q3 | $873M | Buy |
12,098,628
+173,380
| +1% | +$12.5M | 2.17% | 23 |
|
|
2014
Q2 | $742M | Buy |
11,925,248
+2,187,583
| +22% | +$136M | 1.87% | 26 |
|
|
2014
Q1 | $664M | Sell |
9,737,665
-498,612
| -5% | -$34M | 1.73% | 27 |
|
|
2013
Q4 | $720M | Sell |
10,236,277
-32,535
| -0.3% | -$2.29M | 1.88% | 24 |
|
|
2013
Q3 | $741M | Sell |
10,268,812
-1,076,505
| -9% | -$77.7M | 2.07% | 22 |
|
|
2013
Q2 | $632M | Buy |
+11,345,317
| New | +$632M | 2.13% | 26 |
|